Interim report for the six months ended June 30, 2008

 | Source: Affitech A/S Affitech A/S 

Summary: For the first six months of 2008 the Pharmexa Group generated revenues
and other operating income of DKK 12,659 thousand and a net loss of DKK 75,914
thousand. Research and development costs totalled DKK 76,558 thousand. The
Pharmexa Group retains its financial forecast for the full year.

Attachments

pharmexa press release 2008-20-uk.pdf
GlobeNewswire